[ChinaNet Online Holdings, Inc. Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 § First quarter 2010 adjusted net income § Company launches new growth initiatives § Company reaffirmed 2010 revenue guidance of $45.0 million and adjusted net income guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue and adjusted net income, respectively § Management]
[ChinaNet Online Holdings, Inc. Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 § First quarter 2010 adjusted net income § Company launches new growth initiatives § Company reaffirmed 2010 revenue guidance of $45.0 million and adjusted net income guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue and adjusted net income, respectively § Management]
[ChinaNet Onlines, Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 First quarter 2010justed netomempany launches new growth initiativesmpany reaffirmed 2010 revenue guidance of $45.0 million andjusted netome guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue andjusted netome, respectively]
[ChinaNet Onlines, Reports First Quarter 2010 Financial Results Beijing, China, May 17, 2010 First quarter 2010justed netomempany launches new growth initiativesmpany reaffirmed 2010 revenue guidance of $45.0 million andjusted netome guidance of $14.1 million, representing 19.0% and 67.9% growth over 2009 revenue andjusted netome, respectively]
[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]
[NEWS RELEASE Skystar Bio-Pharmaceutical Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010 Gross Margin of 53%; $0.15 Diluted Earnings Per Share; Fiscal 2010 Top Line Guidance Increased to $45.5 Million to $47.5 Million XI’AN, CHINA – May 18, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), First Quarter 2009 Highligh ts]
[American Lorain Corporation First Quarter 2010 Earnings Conference Call May 13, 2010 Operator: th Good morning ladies and gentlemen. Thank you for standing by. Welcome to the American Lorain First Quarter 2010 Earnings Conference Call. During todays presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be open for questions. If you have a] [_____________________________________________ FORM 8-K CURRENT REPORT May 13, 2010 Date of report (Date of earliest event reported) AMERICAN LORAIN CORPORATION Nevada 001-34449 87-0430320 (State or other jurisdiction of (I.R.S. employer incorporation) identification no.) Beihuan Road Junan County Shandong, China 276600 (Zip Code) (86) 539-7318818 Item 2.02. Results of Operations and Financial Condition. Item 9.01. (d) 99.1 Transcript of conference call hosted]
[American Lorain Corporation First Quarter 2010 Earnings Conference Call May 13, 2010 Operator: th Good morning ladies and gentlemen. Thank you for standing by. Welcome to the American Lorain First Quarter 2010 Earnings Conference Call. During todays presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be open for questions. If you have a] [_____________________________________________ FORM 8-K CURRENT REPORT May 13, 2010 Date of report (Date of earliest event reported) AMERICAN LORAIN CORPORATION Nevada 001-34449 87-0430320 (State or other jurisdiction of (I.R.S. employer incorporation) identification no.) Beihuan Road Junan County Shandong, China 276600 (Zip Code) (86) 539-7318818 Item 2.02. Results of Operations and Financial Condition. Item 9.01. (d) 99.1 Transcript of conference call hosted]
